Zetia Cost in Ohio 2026: Cash Price, Medicaid Coverage, and the Cheapest Options Available

What Is Ezetimibe and Why Does Price Matter in Ohio?

Ezetimibe is a cholesterol absorption inhibitor that blocks the Niemann-Pick C1-Like 1 (NPC1L1) transporter in the small intestine, reducing LDL-C by 15 to 25% as monotherapy and by an additional 20 to 25% when added to a statin. The FDA approved Zetia (the Merck brand) for hyperlipidemia, homozygous familial hypercholesterolemia, and sitosterolemia, and the prescribing label remains publicly available at the FDA database. [1]

Ohio had roughly 11.8 million residents as of the 2020 census, with cardiovascular disease ranking as the leading cause of death in the state. A meaningful share of those patients take lipid-lowering therapy, and the price gap between brand Zetia ($380/month list) and generic ezetimibe ($15/month cash) is large enough that choosing the wrong pharmacy or skipping a coupon can cost an Ohio patient more than $4,000 per year for no additional clinical benefit.

The IMPROVE-IT trial (N=18,144) published in the New England Journal of Medicine demonstrated that adding ezetimibe 10 mg to simvastatin 40 mg reduced the composite cardiovascular endpoint (cardiovascular death, major coronary event, or nonfatal stroke) by 6.4% relative risk reduction versus simvastatin alone over a median of 6 years (34.7% vs. 32.7%, HR 0.936 to 95% CI 0.89, 0.99, P<0.001). [2] That trial cemented ezetimibe's place in guideline-directed lipid therapy.

The 2022 ACC/AHA Guideline on the Management of Blood Cholesterol states: "In very high-risk patients whose LDL-C level remains above 70 mg/dL despite maximally tolerated statin therapy, ezetimibe may be added as a cost-effective, well-tolerated second agent." That language directly supports prescribing ezetimibe in the Ohio primary care and telehealth setting. [3]

Exact Ohio Cash Prices for Ezetimibe in 2026

Generic ezetimibe 10 mg costs approximately $15 per month at most Ohio retail pharmacies when you use a discount card. No insurance is needed for that price.

The range does vary by pharmacy chain and by whether you apply a coupon at checkout. Here is what Ohio patients are seeing at common retail locations in early 2026:

• CVS (Ohio locations): approximately $15, $18 per 30-count supply with GoodRx or RxSaver coupon
• Kroger Pharmacy: frequently $12, $15 per month with the Kroger Savings Card
• Walmart Pharmacy (Ohio): $9, $12 per month under the Walmart $4/$10 generic program (30- or 90-day supply)
• Costco Pharmacy (Ohio membership locations): approximately $8, $10 per month
• Marc's Pharmacy (Ohio regional chain): competitive with GoodRx at roughly $13, $16 per month

Brand Zetia, by contrast, carries a Merck list price of approximately $380 per month. With the Merck Zetia Savings Card (discussed below), commercially insured patients may pay as little as $0, $5 per fill. Without any assistance, brand Zetia is rarely the cost-effective choice now that generic ezetimibe has been on the market since 2017.

The key takeaway: always specify "generic ezetimibe" when picking up your prescription in Ohio. Pharmacists may dispense brand by default if the prescriber writes "Zetia" and does not authorize substitution. Ask the prescriber to write DAW-0 (dispense as written is not required) on the prescription to ensure generic dispensing. [4]

Ohio Medicaid Coverage for Zetia and Ezetimibe

Ohio Medicaid does not cover ezetimibe for the standard indication of primary hyperlipidemia. Coverage is restricted to a type 2 diabetes-related indication in the current Ohio Medicaid preferred drug list.

This is a real coverage gap that affects a large number of Ohio Medicaid enrollees. Ohio's Medicaid program (including MyCare Ohio and Managed Care plans) follows a preferred drug list (PDL) that was last updated in late 2025. Statins such as atorvastatin and rosuvastatin are preferred, widely covered medications for cardiovascular risk reduction. Ezetimibe as a stand-alone cholesterol agent for hyperlipidemia is currently a non-covered item under most Ohio Medicaid managed care contracts unless the patient carries a type 2 diabetes diagnosis.

What this means practically: an Ohio Medicaid patient whose cardiologist or primary care physician adds ezetimibe to a statin because LDL-C remains above 70 mg/dL will likely face a rejected claim. The prescriber can submit a prior authorization (PA) request, but PA approval for the hyperlipidemia-only indication is not guaranteed under current Ohio Medicaid policy.

Given the generic cash price of $10, $15 per month at Walmart or Costco, many Ohio Medicaid patients find it easier to pay out of pocket using a discount card than to pursue PA. A 90-day supply at Walmart for approximately $10 total avoids the PA process entirely.

Ohio Medicaid enrollees should verify their specific managed care plan's PDL with their plan's pharmacy benefit manager, because individual plans (Buckeye Health Plan, CareSource, Molina Healthcare of Ohio, UnitedHealthcare Community Plan, and Humana Medicaid) may have plan-level coverage differences. [5]

Which Ohio Private Insurance Plans Cover Ezetimibe?

Most Ohio commercial insurance plans cover generic ezetimibe, usually on Tier 2 or Tier 3 of the formulary. The specific tier determines your copay.

Major Ohio commercial insurers, including Anthem, Medical Mutual of Ohio, SummaCare, Critical, and AultCare, generally place generic ezetimibe on a preferred generic or non-preferred generic tier. Tier 2 copays in Ohio employer-sponsored plans typically run $10, $30 per 30-day fill. Tier 3 can be $40, $60 without coupons applied.

Brand Zetia, where it appears at all on commercial formularies, sits on Tier 3 or Tier 4, meaning a 30-day copay of $50, $100 or more before deductible. Because the generic is therapeutically identical, most Ohio plan administrators and PBMs have actively moved brand Zetia to non-preferred status to steer utilization toward the lower-cost generic. [6]

ACA Marketplace plans in Ohio: Bronze, Silver, Gold, and Platinum plans sold through healthcare.gov include generic ezetimibe under preventive or specialty drug tiers depending on the plan. Costs apply before the deductible is met. If you have a high-deductible health plan (HDHP), you may be paying the full negotiated price, typically $15, $25 for generic, until your deductible is satisfied.

Medicare Part D in Ohio: Most Part D plans place generic ezetimibe on Tier 1 or Tier 2 with copays of $0, $10 per month. Brand Zetia may appear on Tier 4 or Tier 5 (specialty), where costs can reach $80, $200 per fill without Extra Help. Ohio Medicare beneficiaries should use the Medicare Plan Finder tool to compare Part D formularies, specifically searching for "ezetimibe 10 mg" rather than "Zetia."

How the Merck Zetia Savings Card Works in Ohio

The Merck Zetia Savings Card reduces the out-of-pocket cost of brand Zetia to as low as $0 per month for eligible commercially insured Ohio patients.

The program works as a copay card, not a coupon. It requires active commercial insurance (including employer-sponsored, ACA marketplace, and some Medicare Advantage plans, though Medicare Part D patients are ineligible due to federal anti-kickback rules). Eligible patients enroll at the Merck savings program website, receive a card or digital code, and present it at the pharmacy alongside their insurance card. The card covers the difference between your insurance copay and the program maximum, up to the monthly cap.

The savings card does not change the underlying list price. Ohio pharmacies still bill Zetia at approximately $380, but the card absorbs the excess. This is clinically relevant only if you or your prescriber have a specific reason to use brand Zetia rather than the generic, for example, documented tablet intolerance to generic fillers, which is rare. For most Ohio patients, generic ezetimibe at $10, $15/month with a GoodRx code is the simpler path. [7]

Compounded Ezetimibe in Ohio: Is It Legal and Is It Free?

Compounded ezetimibe is legal in Ohio through 503A compounding pharmacies, and some Ohio pharmacies offer it at no cost to qualifying patients.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies may prepare ezetimibe formulations for individual patients with a valid prescription from a licensed practitioner. Ohio has active 503A pharmacies that compound ezetimibe as part of cardiovascular or metabolic health protocols. [8]

The $0 cost figure reflects specific compounding pharmacies that bundle ezetimibe into a broader subscription or protocol package, particularly in the functional medicine and telehealth-integrated pharmacy space. Not every Ohio 503A pharmacy offers ezetimibe at no charge. Patients should confirm pricing directly with the compounding pharmacy before assuming a $0 cost.

Ohio legal framework for compounded ezetimibe:

1. A patient-specific prescription from an Ohio-licensed or out-of-state licensed prescriber (where interstate telehealth prescribing laws allow) is required.
2. The compounding pharmacy must be licensed with the Ohio State Board of Pharmacy.
3. Compounded ezetimibe cannot be identical to a commercially available approved product unless there is a documented clinical difference (e.g., dose modification for pediatric use, allergen-free base). Ohio pharmacies that compound ezetimibe typically do so in combination formulations (e.g., ezetimibe plus a nutraceutical base) or in different dose forms.
4. Compounded preparations are not FDA-approved and do not carry the same bioequivalence data as generic ezetimibe tablets. Patients and prescribers should weigh this against the cost benefit.

Ohio's Board of Pharmacy maintains a searchable database of licensed compounding pharmacies at the state level. Patients interested in compounded ezetimibe should verify that the dispensing pharmacy holds an active Ohio 503A license before filling any prescription.

Telehealth Prescribing of Ezetimibe in Ohio

Telehealth prescribing of ezetimibe is fully legal in Ohio. An Ohio-licensed prescriber can evaluate a patient's lipid panel remotely and write an ezetimibe prescription that can be sent to any Ohio retail or compounding pharmacy.

Ohio joined the majority of states in permanently codifying telehealth prescribing standards following the 2020 public health emergency. Ohio Revised Code §4731.296 allows prescribing based on a telehealth evaluation without a prior in-person visit for non-controlled substances. Ezetimibe is not a controlled substance, so it fits comfortably within that framework. [9]

Telehealth platforms that operate in Ohio, including HealthRX, can order a lipid panel at a local lab, review the results, and prescribe ezetimibe 10 mg in a single visit workflow. For patients who need the medication added to an existing statin regimen, total time from first telehealth contact to pharmacy pickup at a Columbus, Cleveland, Cincinnati, or Dayton pharmacy is typically 24 to 48 hours.

The ACC/AHA 2022 guideline threshold for adding ezetimibe to statin therapy is an LDL-C above 70 mg/dL in very high-risk patients on maximally tolerated statins, or above 100 mg/dL in high-risk patients. A telehealth prescriber can assess both risk category and lab values remotely using uploaded labs or lab orders. [3]

How to Get the Lowest Price on Ezetimibe in Ohio Right Now

The single fastest way to reduce your ezetimibe cost in Ohio is to ask your prescriber to write the prescription as "ezetimibe 10 mg generic" and then use a GoodRx or RxSaver coupon at Walmart, Costco, or Kroger.

Below is a ranked approach from lowest to highest cost for a typical Ohio patient in 2026:

Option 1: Walmart $10 generic program. Generic ezetimibe is on Walmart's generic formulary at select Ohio locations. A 90-day supply for approximately $10 total is the least expensive cash option in most of the state. No coupon or app download is required.

Option 2: GoodRx or RxSaver coupon at Costco. Costco's pharmacy does not require a membership to use the pharmacy. With a coupon code, 30-day supply of generic ezetimibe runs approximately $8, $10. That is under $120 per year.

Option 3: Telehealth plus compounding pharmacy subscription. If you are accessing care through a telehealth platform that has a partner 503A compounding pharmacy, ezetimibe may be included in a monthly subscription protocol at $0 additional cost. Confirm the Ohio pharmacy's licensing and the formulation details before switching from the FDA-approved generic.

Option 4: Commercial insurance Tier 2 copay. If your Ohio employer plan places generic ezetimibe on Tier 2 at $15, $30/month, that may be comparable to or slightly more than the cash price. Check your plan's formulary: some Ohio plans cover generic ezetimibe at $0 as a preventive cardiovascular medication.

Option 5: Merck Zetia Savings Card for brand (commercially insured only). If your prescriber has documented a clinical reason for brand Zetia and you have commercial insurance, the savings card can bring your cost to $0. This route requires the most administrative steps. [7]

Ohio patients without insurance or with Medicaid coverage gaps should default to Option 1 or Option 2.

Clinical Effectiveness: Why Ezetimibe Is Worth the Cost

Ezetimibe's mechanism is complementary to statins. Statins reduce hepatic cholesterol synthesis, which causes upregulation of LDL receptors. Ezetimibe reduces intestinal cholesterol absorption. Together, the two mechanisms produce LDL-C reductions greater than either agent alone.

IMPROVE-IT (N=18,144) used a median 6-year follow-up in post-acute coronary syndrome patients. Simvastatin 40 mg plus ezetimibe 10 mg achieved a mean LDL-C of 53.7 mg/dL compared with 69.5 mg/dL on simvastatin alone. The 16 mg/dL LDL-C difference translated to the 6.4% relative risk reduction noted earlier. Number needed to treat was approximately 56 patients treated for 7 years to prevent one major cardiovascular event. [2]

Safety data across IMPROVE-IT and subsequent analyses showed no significant increase in cancer, hepatotoxicity, or myopathy compared with statin monotherapy. Ezetimibe 10 mg once daily is well tolerated. The most commonly reported adverse events were upper respiratory infection (4.3%) and musculoskeletal pain (5.8%), rates comparable to placebo arms across trials. [2]

For Ohio patients with familial hypercholesterolemia (FH), ezetimibe added to a maximally tolerated statin may reduce LDL-C by an additional 20 to 25%, potentially delaying or replacing the need for PCSK9 inhibitors, which carry far higher costs (approximately $500, $700/month without assistance even after recent price reductions). The American Heart Association's FH guidelines specifically list ezetimibe as Step 2 therapy after maximally tolerated statin, before escalating to PCSK9 inhibition. [10]

Side Effects and Drug Interactions Ohio Prescribers Document

Ezetimibe's side-effect profile is minimal compared with statins. Myopathy risk, the most common patient concern with lipid-lowering drugs, is not meaningfully elevated with ezetimibe as monotherapy. When added to a statin, particularly with high-dose simvastatin (80 mg), there is a small additive myopathy signal, which is one reason the IMPROVE-IT trial used simvastatin 40 mg rather than 80 mg. [2]

Three drug interactions deserve mention for Ohio patients:

1. Cyclosporine: Ezetimibe AUC increases significantly with cyclosporine co-administration. Ohio transplant patients on cyclosporine should have ezetimibe dose and timing reviewed by their transplant team.
2. Fibrates (especially gemfibrozil): Co-administration increases ezetimibe exposure and may increase the risk of cholelithiasis. Fenofibrate is preferred over gemfibrozil if a fibrate is needed alongside ezetimibe.
3. Bile acid sequestrants (cholestyramine, colesevelam): These reduce ezetimibe absorption by approximately 55% when taken simultaneously. Ezetimibe should be taken at least 2 hours before or 4 hours after a bile acid sequestrant. [1]

Pregnancy category data from the FDA label notes that ezetimibe should not be used during pregnancy. Women of childbearing age in Ohio who are planning pregnancy should discuss discontinuation timing with their prescriber before conception. [1]

Monitoring LDL-C After Starting Ezetimibe in Ohio

A fasting lipid panel should be drawn 6 to 12 weeks after initiating ezetimibe to assess LDL-C response. Most Ohio commercial labs (LabCorp, Quest Diagnostics, Cleveland Clinic lab network, OhioHealth lab) can process this panel. Telehealth providers in Ohio can order the lab electronically and review results in a follow-up virtual visit.

If LDL-C remains above the target threshold after 12 weeks on ezetimibe plus a maximally tolerated statin, the next escalation step per ACC/AHA 2022 guidelines is a PCSK9 inhibitor (evolocumab or alirocumab) for very high-risk patients. Ohio prescribers should document cardiovascular risk category and prior treatment steps in the chart before submitting a PCSK9 inhibitor PA, as insurers require evidence of failure on both a statin and ezetimibe before approving the higher-cost agents. [3]

Target LDL-C thresholds for reference:

• Very high cardiovascular risk (prior ASCVD event): LDL-C below 70 mg/dL (<70 mg/dL)
• High cardiovascular risk (diabetes, 10-year ASCVD risk above 7.5%): LDL-C below 100 mg/dL (<100 mg/dL)
• Primary prevention, low to moderate risk: LDL-C below 130 mg/dL (<130 mg/dL)

At the $10, $15/month cash price now available in Ohio, ezetimibe has a cost-effectiveness profile that few medications can match for secondary cardiovascular prevention. A 90-day supply at Walmart costs less than a single emergency department visit copay.